Cetuximab (C225) plus irinotecan/cisplatin (CPT/Cis) for CPT/Cis-refractory esophageal cancer Meeting Abstract

  


Authors: Ku, G. Y.; Shah, M. A.; Tang, L. H.; Miron, B.; Kelsen, D. P.; Ilson, D. H.
Abstract Title: Cetuximab (C225) plus irinotecan/cisplatin (CPT/Cis) for CPT/Cis-refractory esophageal cancer
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 661s
Language: English
ACCESSION: WOS:000208457401230
PROVIDER: wos
DOI: 10.1200/jco.2008.26.15_suppl.15580
Notes: Meeting Abstract : 15580 -- Available in online publication only -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Geoffrey Yuyat Ku
    230 Ku
  2. Manish Shah
    177 Shah
  3. Laura Hong Tang
    447 Tang
  4. David H Ilson
    433 Ilson
  5. David P Kelsen
    537 Kelsen
  6. Benjamin Miron
    5 Miron
Related MSK Work